Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The itaconate pathway is a metabolic and immunoregulatory axis centered on the production and function of itaconate in immune cells, primarily activated macrophages. It links cellular metabolism with innate immunity, inflammation control, and host defense. Key functions include antimicrobial activity, immunomodulation, and metabolic reprogramming. It exerts its effects through mechanisms such as protein alkylation and enzyme inhibition, making it a potential therapeutic target for diseases involving excessive inflammation or dysregulated immunity.
Inhibition of bacterial isocitrate lyase (ICL); Inhibition of succinate dehydrogenase (SDH); Covalent modification (alkylation) of cysteine residues on target proteins
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Itaconate Pathway (None).